Endo Inc.

OTCPK:ENDP.Q Rapporto sulle azioni

Cap. di mercato: US$141.1k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Endo International Salute del bilancio

Salute finanziaria criteri di controllo 2/6

Endo International has a total shareholder equity of $-6.6B and total debt of $8.1B, which brings its debt-to-equity ratio to -123.5%. Its total assets and total liabilities are $5.1B and $11.7B respectively.

Informazioni chiave

-123.5%

Rapporto debito/patrimonio netto

US$8.15b

Debito

Indice di copertura degli interessin/a
ContantiUS$777.92m
Patrimonio netto-US$6.60b
Totale passivitàUS$11.73b
Totale attivitàUS$5.14b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Endo creditors looking at putting company up for sale through bankruptcy - Bloomberg

Aug 16

Endo International sees 23% rise on 3x higher than normal volume

Aug 03

Endo outperforms defying bankruptcy fears and generic entry

Jul 25

Endo weighs bankruptcy filing without opioid settlement - WSJ

Jul 12

Endo International cools off, giving back some of its 85% Tuesday gain

Jun 29

Endo: Stick A Fork In It

May 10

Endo: About As Bad As It Gets

Mar 07

Endo: FDA Approves Generic Form Of Vasostrict Creating Headwind Into Next Year

Dec 16

Endo: A Win In California But Equity Value Still A Question

Nov 02

Endo International: Loses Vasostrict Trial

Aug 31

Endo International: Hires Restructuring Advisor

Aug 20

Endo International: All About Ongoing Litigation

Aug 07

Endo: Appellate Court Denies Request To Postpone Damages Trial Might Be End O' The Road

Jul 15

Endo International: Bankruptcy Seems Like The Only Practical Option

Jun 30

Endo International wins FDA approval for Micafungin new formulation

Jun 17

Endo International plc 2021 Q1 - Results - Earnings Call Presentation

May 07

Radius Health partners with Endo unit for abaloparatide in Canada

Jan 05

Analisi della posizione finanziaria

Passività a breve termine: ENDP.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Passività a lungo termine: ENDP.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: ENDP.Q has negative shareholder equity, which is a more serious situation than a high debt level.

Riduzione del debito: ENDP.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: Whilst unprofitable ENDP.Q has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Previsione Cash Runway: ENDP.Q is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 0.8% per year.


Scoprire le aziende sane